Mylan, a generic form of current #MS treatment dimethyl fumarate, given favourable court ruling in the US. https://teapaw.org/t.co/pghwgyLKxF. Visit neuro-compass.education/ for up to date expert-led #MS content!
New survey finds majority of people with #MS use complementary and alternative medicine. https://teapaw.org/t.co/WgsS23uOF6. Visit neuro-compass.education/ for up to date expert-led #MS content!
Neurological disability, age and obesity found to be risk factors for severe COVID-19 in #MS patients, but not DMT exposure. https://teapaw.org/t.co/8DR0pxUPJP. Visit neuro-compass.education/ for up to date expert-led #MS content!
Hookworm trial shows evidence of immune system regulation and potential benefit for #MS patients. https://teapaw.org/t.co/6wnPRvIPaa. Visit neuro-compass.education/ for up to date expert-led #MS content!
Serum NfL levels may be predictive of long-term clinical outcomes in #MS. go.nature.com/3i5pw4d. Visit neuro-compass.education/ for up to date expert-led #MS content!
Enrolment begins for Phase I trial of potential new relapsing #MS treatment, SAR442168. https://teapaw.org/t.co/1dlkxBK4B6. Visit neuro-compass.education/ for up to date expert-led #MS content!
Changes in UK COVID-19 advice announced for those shielding, which may include some #MS patients. https://teapaw.org/t.co/QE5Fukp0ti. Visit neuro-compass.education/ for up to date expert-led #MS content!
US and UK #MS patients at increased risk of depression compared with non-MS patients. https://teapaw.org/t.co/gLWMYiU8WM. Visit neuro-compass.education/ for up to date expert-led #MS content!
Switching from natalizumab to another #MS DMT may increase risk of relapse. https://teapaw.org/t.co/Zpwobr4Yof. Visit neuro-compass.education/ for up to date expert-led #MS content!
FDA extends review process for potential new #MS drug ofatumumab by 3 months. reut.rs/2zRKN07. Visit neuro-compass.education/ for up to date expert-led #MS content!
Fatigue, sleep disturbance and pain may be first signs of #MS. https://teapaw.org/t.co/TqZ9RAEUVh. Visit neuro-compass.education/ for up to date expert-led #MS content!
Lipid mediator profiles predict response to therapy with an oral frankincense extract in relapsing-remitting #MS. go.nature.com/2MbIxmI. Visit neuro-compass.education/ for up to date expert-led #MS content!
People living in urban areas are 30% more likely to develop #MS than those living in rural areas. https://teapaw.org/t.co/EoetoXxMal. Visit neuro-compass.education/ for up to date expert-led #MS content!
EMA approves reduced infusion time for #MS patients taking ocrelizumab. https://teapaw.org/t.co/5ThjK9QgoS. Visit neuro-compass.education/ for up to date expert-led #MS content!
1
Higher levels of blood NfL associated with the risk of worse #MS disability over time. https://teapaw.org/t.co/5CPOLP8nlN. Visit neuro-compass.education/ for up to date expert-led #MS content!
European Commission approves ozanimod for the treatment of adults with active relapsing-remitting #MS. https://teapaw.org/t.co/pHdIjIa2tC. Visit neuro-compass.education/ for up to date expert-led #MS content!
Increases in disability reduced by long-term fingolimod use for secondary progressive #MS patients. https://teapaw.org/t.co/WiHjpO9K52. Visit neuro-compass.education/ for up to date expert-led #MS content!




















